IM Cannabis Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals: Other
  • ISIN: CA44969Q3070
CAD
5.10
-3.4 (-40.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

46.89 k

Shareholding (Mar 2025)

FII

6.99%

Held by 22 FIIs

DII

93.01%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals: Other

stock-summary
Market cap

CAD 16 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

2.65

stock-summary
Return on Equity

-109.22%

stock-summary
Price to Book

2.96

Revenue and Profits:
Net Sales:
12 Million
(Quarterly Results - Mar 2025)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
68.87%
0%
68.87%
6 Months
17.24%
0%
17.24%
1 Year
7.59%
0%
7.59%
2 Years
214.81%
0%
214.81%
3 Years
304.76%
0%
304.76%
4 Years
-98.43%
0%
-98.43%
5 Years
-96.83%
0%
-96.83%

IM Cannabis Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
122.91%
EBIT Growth (5y)
-253.92%
EBIT to Interest (avg)
-4.31
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
3.23
Sales to Capital Employed (avg)
2.13
Tax Ratio
14.44%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.64%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.11
EV to EBIT
-2.33
EV to EBITDA
-3.00
EV to Capital Employed
1.03
EV to Sales
0.42
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-44.04%
ROE (Latest)
-229.07%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 22 Foreign Institutions (6.99%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -6.02% vs -4.32% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 116.67% vs -9.09% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.50",
          "val2": "13.30",
          "chgp": "-6.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.60",
          "val2": "0.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.70",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.20",
          "val2": "-1.20",
          "chgp": "116.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.60%",
          "val2": "-21.50%",
          "chgp": "3.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.66% vs -10.13% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -15.69% vs 59.04% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "54.00",
          "val2": "48.80",
          "chgp": "10.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.80",
          "val2": "-9.20",
          "chgp": "47.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.50",
          "val2": "3.70",
          "chgp": "21.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.20",
          "val2": "-0.60",
          "chgp": "133.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.80",
          "val2": "-10.20",
          "chgp": "-15.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-129.60%",
          "val2": "-249.50%",
          "chgp": "11.99%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQstock-summary
Mar'25
Dec'24
Change(%)
Net Sales
12.50
13.30
-6.02%
Operating Profit (PBDIT) excl Other Income
0.60
0.30
100.00%
Interest
0.00
0.70
-100.00%
Exceptional Items
0.00
0.20
-100.00%
Consolidate Net Profit
0.20
-1.20
116.67%
Operating Profit Margin (Excl OI)
12.60%
-21.50%
3.41%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2025 is -6.02% vs -4.32% in Dec 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is 116.67% vs -9.09% in Dec 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
54.00
48.80
10.66%
Operating Profit (PBDIT) excl Other Income
-4.80
-9.20
47.83%
Interest
4.50
3.70
21.62%
Exceptional Items
0.20
-0.60
133.33%
Consolidate Net Profit
-11.80
-10.20
-15.69%
Operating Profit Margin (Excl OI)
-129.60%
-249.50%
11.99%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 10.66% vs -10.13% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -15.69% vs 59.04% in Dec 2023

stock-summaryCompany CV
About IM Cannabis Corp. stock-summary
stock-summary
IM Cannabis Corp.
Pharmaceuticals: Other
IM Cannabis Corp., formerly Navasota Resources Inc., is a Canada-based medical cannabis company. The company is focused on offering a full spectrum of government-licensed cannabis products, from generic to good manufacturing practice (GMP) certified and pharmaceutical-grade, for both wholesale and retail clients. The Company operates in the Israeli medical cannabis market by providing intellectual property and services to licensed producers. The Company has three wholly-owned subsidiaries: IMC, incorporated, IMC Portugal and IM Cannabis Canada Inc. The Company also has four partially-owned subsidiaries Adjupharm GmbH, IMC Ventures Ltd., Societe Amig Navasota Mining International S.A.R.L., and Africa Bauxite Corporation.
Company Coordinates stock-summary
Company Details
550 Burrard Street, Suite 2300 , VANCOUVER BC : V6C 2B5
stock-summary
Tel: 1 416 8640578
stock-summary
stock-summary
Registrar Details